Literature DB >> 1509156

Acute renal failure in natural disasters.

E K Noji1.   

Abstract

Sudden-impact natural disasters such as earthquakes present a serious challenge to medical personnel in both developed and less developed countries. Crush syndrome with acute renal failure has been identified as a major medical complication that occurs among people whose limbs are trapped by heavy objects during natural disasters such as earthquakes or volcanic eruptions. Rescue and field medical teams should be trained to recognize and promptly treat the problems associated with prolonged limb compression and should carry the appropriate fluids and medications to treat the complications of traumatic rhabdomyolysis. Early, aggressive volume replacement followed by forced solute-alkaline diuresis therapy may protect the kidney against acute renal failure. Better epidemiologic knowledge of the specific disaster conditions that predispose traumatic rhabdomyolysis to develop is clearly essential for those who must determine when emergency dialysis services are required in response to injuries sustained during natural disasters. Disaster health care personnel involved with providing emergency acute renal care should have a basic familiarity with disaster epidemiology in order to determine whether a given event requires their intervention. This paper includes recommendations for improving medical planning, preparedness, and response to natural disasters that cause acute renal failure.

Entities:  

Mesh:

Year:  1992        PMID: 1509156     DOI: 10.3109/08860229209106625

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  2 in total

1.  Stabilization of surface-bound antibodies for ELISA based on a reversable zeolitic imidazolate framework-8 coating.

Authors:  Lin Kang; Steve Smith; Congzhou Wang
Journal:  J Colloid Interface Sci       Date:  2020-12-24       Impact factor: 8.128

2.  Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway.

Authors:  Bo-Shi Fan; En-Hui Zhang; Miao Wu; Jin-Min Guo; Ding-Feng Su; Xia Liu; Jian-Guang Yu
Journal:  Front Pharmacol       Date:  2016-03-29       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.